Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$235,815
+$41,330 QoQ
Shares Held
12,733
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $13,612,825 across 48 Drug Manufacturers - Specialty & Generic names. TAK ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
65,808 | $7,779,163 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
46,558 | $2,406,583 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,507 | $1,120,712 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,083 | $642,197 | |
| 5 | VTRS |
Viatris Inc
|
21,979 | $296,936 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
12,733 | $235,815 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
16,116 | $223,206 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
8,810 | $210,823 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $235,815 | 12,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $194,485 | 12,475 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $180,145 | 12,305 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $175,579 | 11,357 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $160,551 | 10,797 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $126,865 | 9,582 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $90,439 | 6,360 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $95,173 | 7,355 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $88,507 | 6,372 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $90,400 | 6,335 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $95,651 | 6,183 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $45,983 | 2,927 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $50,379 | 3,057 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $43,539 | 2,791 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $37,236 | 2,871 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,525 | 536 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,002 | 70 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $954 | 70 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,146 | 70 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,178 | 70 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,278 | 70 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,274 | 70 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,248 | 70 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,514 | 196 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,062 | 70 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||